Regulations.gov document
Interim Response Letter from FDA to BioNeutra North America Inc
Other · FDA-2019-P-2239 · posted Nov 12, 2019
Key facts
| Document ID | FDA-2019-P-2239-0008 |
|---|---|
| Title | Interim Response Letter from FDA to BioNeutra North America Inc |
| Document type | Other |
| Subtype | Letter(s) |
| Agency | FDA |
| Docket | FDA-2019-P-2239 |
| Posted | Nov 12, 2019 |
| Comment period opens | Nov 12, 2019 |
At a glance
- 1–9 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: